Midodrine

Primary Uses

Midodrine is primarily used to manage symptomatic orthostatic hypotension. This condition occurs when blood pressure falls sharply after a person changes position, such as standing up from a sitting or lying position. This drop in pressure can lead to symptoms that interfere with daily life, including:

• Severe dizziness or lightheadedness
• Feeling faint or passing out
• Blurred vision
• Weakness

When It Is Prescribed

Because midodrine can significantly raise blood pressure even when a person is lying down, it is generally reserved for specific situations. Healthcare providers typically prescribe it when:

• The symptoms of orthostatic hypotension are severe enough to considerably impair the person's quality of life.
• Other standard treatments, such as increased salt intake, compression stockings, or lifestyle adjustments, have not provided enough relief.

The goal of treatment is to help patients perform daily activities more easily by stabilizing their blood pressure while they are upright. It works by narrowing the blood vessels, which increases blood pressure.

Mechanism of Action

Midodrine belongs to a class of medications known as alpha-1 agonists. When you take midodrine, your body converts it into an active substance called desglymidodrine. This active form works by stimulating specific receptors, called alpha-1 receptors, located in the walls of your blood vessels.

How It Affects Blood Pressure

When these receptors are activated, the following occurs:

• Vessel Constriction: The smooth muscles in the walls of the arteries and veins tighten or narrow.
• Increased Resistance: This narrowing increases the resistance to blood flow throughout the body.
• Blood Pressure Elevation: As the vessels tighten, blood pressure rises, which helps ensure that enough blood reaches the brain and other organs when a person is upright.

Midodrine is specifically used to treat symptomatic orthostatic hypotension, a condition where blood pressure drops significantly upon standing. By tightening the blood vessels, the medication helps prevent blood from pooling in the lower body, which reduces symptoms like dizziness or fainting. Unlike some other blood pressure medications, midodrine primarily affects the blood vessels and does not typically have a significant effect on the heart rate.

Common Side Effects

• Tingling, itching, or numbness, particularly on the scalp
• Goosebumps or skin crawling sensations
• Chills
• Urinary problems, including an urgent need to urinate, frequent urination, or difficulty starting urination
• Stomach pain or pressure

Serious Side Effects

Contact your healthcare provider immediately if you experience any of the following serious symptoms:

• High blood pressure while lying down (supine hypertension), which may cause pounding in the ears, blurred vision, or a severe headache
• Slow heart rate (bradycardia)
• Chest pain or pressure
• Shortness of breath
• Dizziness or fainting
• Confusion

Supine Hypertension Warning

The most serious risk associated with midodrine is a significant increase in blood pressure while lying down (supine hypertension). This elevation in blood pressure can be severe and may increase the risk of cardiovascular complications. Due to this risk, midodrine is only indicated for people whose low blood pressure significantly impairs their daily life and has not improved with other clinical care.

To manage the risk of high blood pressure while resting, the following precautions are typically observed:

• Doses are taken during the day while the person is upright and active.
• The final dose of the day is generally taken at least four hours before going to sleep.
• Blood pressure is monitored regularly in various positions, including lying down and standing.
• If symptoms of high blood pressure occur—such as headache, blurred vision, or a pounding sensation in the ears—medical attention is necessary.

Contraindications

Midodrine is not used in individuals with certain health conditions, including:

• Severe organic heart disease.
• Acute kidney disease or severe kidney impairment.
• Persistent or excessive high blood pressure while lying down.
• Pheochromocytoma (a tumor of the adrenal gland).
• Urinary retention or blockage of the bladder.

Additional Considerations

Heart Rate Changes: Midodrine may slow the heart rate (bradycardia). Caution is necessary when it is used alongside other medications that also reduce heart rate, such as beta-blockers or certain heart medications.

Organ Function: Since the kidneys are responsible for removing the drug from the body, people with kidney impairment may require dose adjustments. The drug should also be used with caution in those with liver problems.

Urinary Health: This medication can cause difficulty with urination. It is used cautiously in people with a history of prostate enlargement or other conditions that affect the bladder.

Pregnancy

There are no adequate and well-controlled studies regarding the use of midodrine in pregnant individuals. It is not known whether midodrine can cause harm to an unborn baby or affect reproductive capacity. Because of this lack of data, midodrine should be used during pregnancy only if the potential benefit clearly outweighs the potential risk to the fetus.

Breastfeeding

It is currently unknown whether midodrine passes into human breast milk. Because many drugs are excreted in human milk, caution is advised when midodrine is used while breastfeeding. There is no information available regarding the effects of the drug on the nursing infant or on milk production.

Consult Your Healthcare Provider

If you are pregnant, planning to become pregnant, or are breastfeeding, it is important to discuss the risks and benefits of midodrine with your healthcare provider to determine the most appropriate treatment plan for your situation.

Midodrine is available in the following form:

• Oral Tablet: This medication is taken by mouth and is typically administered during daytime hours when the patient is upright.

FDA Approval Status

Midodrine was approved by the U.S. Food and Drug Administration (FDA) in 1996 under the accelerated approval regulations (Subpart H). This pathway allows for the approval of drugs that treat serious or life-threatening conditions based on a surrogate endpoint that is likely to predict clinical benefit.

Approved Indications

The medication is indicated for the treatment of symptomatic orthostatic hypotension (OH). It is intended for patients whose lives are significantly impaired by low blood pressure upon standing, and who have not responded sufficiently to non-drug treatments such as support stockings, fluid expansion, or lifestyle changes.

Boxed Warning

Midodrine carries a boxed warning because it can cause a significant increase in blood pressure when a patient is lying down, a condition known as supine hypertension. Because of this risk, the FDA specifies that midodrine should only be used in patients whose symptoms are severely debilitating and for whom the benefits of treatment outweigh the risks of high blood pressure.

Regulatory History

In 2010, the FDA proposed withdrawing approval for midodrine because the required post-marketing studies had not yet confirmed that the drug provided a clinical benefit, such as improved physical ability. However, the drug remains on the market while the FDA continues to review data from additional clinical trials intended to verify its effectiveness.

FDA Indications and Usage

Midodrine is approved by the FDA for the treatment of symptomatic orthostatic hypotension. This condition causes a sharp drop in blood pressure when standing, which can lead to dizziness or fainting. The FDA recommends that midodrine be reserved for patients whose symptoms significantly interfere with daily life and who have not responded sufficiently to other standard treatments.

Boxed Warning: Supine Hypertension

The FDA has included a boxed warning on the labeling for midodrine regarding the risk of supine hypertension. This refers to a potentially dangerous increase in blood pressure that occurs when a person is lying flat. Because of this risk, midodrine should only be used in patients for whom the benefits of treatment outweigh the risks of high blood pressure while resting.

Regulatory Status

Midodrine was granted accelerated approval by the FDA. This status is given to drugs that treat serious or life-threatening illnesses and show promise in providing a clinical benefit. Under this program, the manufacturer may be required to conduct further studies to confirm that the drug effectively improves the patient's ability to perform essential daily activities.